61
Participants
Start Date
April 30, 2004
Primary Completion Date
June 30, 2006
Study Completion Date
March 15, 2022
MRI contrast agent Combidex (ferumoxtran-10)
Combidex as an MR-lymph node contrast agent for the detection of small lymph nodes and lymph metastases.
Princess Margaret Hospital, Toronto
Princess Margaret Hospital, Canada
OTHER
University Health Network, Toronto
OTHER